Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Molecular Oncology|December 25, 2018
Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cellsPurusottam Mohapatra, Chandra Prakash Prasad, Tommy Andersson
Cancers|September 23, 2015
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?Chandra Prakash Prasad, Purusottam Mohapatra, Tommy Andersson
Cancer Metastasis Reviews|September 2, 2018
WNT5A as a therapeutic target in breast cancerChandra Prakash Prasad, Mansi Manchanda, Purusottam Mohapatra, et al.
Biotechnology and Bioengineering|July 13, 2023
Passage number of cancer cell lines: Importance, intricacies, and way-forwardChandra Prakash Prasad, Satyendra Chandra Tripathi, Manish Kumar, et al.
Cancers|February 9, 2020
WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell InvasionPurusottam Mohapatra, Vikas Yadav, Maren Toftdahl, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 16, 2024
Belling the "cat": Wnt/β-catenin signaling and its significance in future cancer therapiesAkansha Goyal, Satyajit Laxman Murkute, Sujoy Bhowmik, et al.
Molecular Oncology|June 4, 2013
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cellsChandra Prakash Prasad, Shivendra Kumar Chaurasiya, Lena Axelsson, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 15, 2016
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transitionChandra Prakash Prasad, Shivendra Kumar Chaurasiya, William Guilmain, et al.
Pageof 27